News

Wegovy, Zepbound and the weight-loss drugs reshaping Americans
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Pharmaceutical Technology on MSN22h
FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency
The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune ...
Dietitian Who Lost 60 Pounds With GLP-1 Drug Reveals Foods to Avoid and Prioritize
She began using Wegovy, the version of Ozempic approved for weight loss, after struggling with obesity. She reveals which ...